DA 7503
Alternative Names: DA-7503Latest Information Update: 26 Sep 2024
Price :
$50 *
At a glance
- Originator Dong-A ST
- Class Antidementias; Small molecules
- Mechanism of Action Tau protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease; Tauopathies
Most Recent Events
- 28 Jul 2024 Pharmacodynamics data from a preclinical trial in Alzheimer's disease and Tauopathies presented at the Alzheimer's Association International Conference 2024 (AAIC-2024)
- 03 May 2024 Preclinical trials in Alzheimer's disease in South Korea (PO) before May 2024 (Dong-A ST pipeline, May 2024)
- 03 May 2024 Preclinical trials in Tauopathies in South Korea (PO) before May 2024 (Dong-A ST pipeline, May 2024)